---
title: 'Trends in the availability and prices of quality-assured tuberculosis drugs:
  a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024'
date: '2024-06-25'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38918859/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240626181739&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: The number of TB drugs available from the GDF has substantially
  increased during its first 23 years of operation. The prices of most APIs for new
  TB treatments decreased or remained stable. The prices of most APIs for standard
  drug-sensitive TB treatment ...'
disable_comments: true
---
CONCLUSIONS: The number of TB drugs available from the GDF has substantially increased during its first 23 years of operation. The prices of most APIs for new TB treatments decreased or remained stable. The prices of most APIs for standard drug-sensitive TB treatment ...